1h Free Analyst Time
The immunoglobulin products market is forecasted to grow by USD 9699.84 million during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the immunoglobulin products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent immunoglobulin product developments, rising prevalence of immunodeficiency disorders and autoimmune diseases, and growing geriatric population.
The immunoglobulin products market is segmented as below:
By Product
- IgG
- IgA
- IgM
- IgD
- IgE
By Route Of Administration
- Intravenous (IV)
- Subcutaneous (SC)
- Intramuscular (IM)
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the immunoglobulin products market covers the following areas:
- Immunoglobulin products market sizing
- Immunoglobulin products market forecast
- Immunoglobulin products market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global immunoglobulin products market: ADMA Biologics Inc., Bio Products Laboratory Ltd., Biocon Ltd., CSL Ltd., GC Biopharma corp. , Grifols SA, Kedrion S.p.A, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., Serum Institute of India Pvt. Ltd., Shanghai RAAS Blood Products Co. Ltd., Taibang Biological Group Co. Ltd., Taj Pharmaceuticals Ltd., and Takeda Pharmaceutical Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in biotechnology and manufacturing processes."
According to the report, one of the major drivers for this market is the recent immunoglobulin product developments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- Biocon Ltd.
- CSL Ltd.
- GC Biopharma corp.
- Grifols SA
- Kedrion S.p.A
- LFB SA
- Novartis AG
- Octapharma AG
- Pfizer Inc.
- Serum Institute of India Pvt. Ltd.
- Shanghai RAAS Blood Products Co. Ltd.
- Taibang Biological Group Co. Ltd.
- Taj Pharmaceuticals Ltd.
- Takeda Pharmaceutical Co. Ltd.
